Pathology Laboratories, Inc. (PathLabs) is pleased to formally announce two (2) new collection devices for Blood Culture specimens. This advanced blood culture media offers both rapid results and superior accuracy. Further details, regarding the collection vials and guidance for use, are provided below. Supplies are immediately available through our Supply Department.

Pathology Laboratories, Inc. (PathLabs) is committed to providing effective, appropriate, and timely patient care by ensuring that our testing reflects medical standards and current guidance. In an audit of our hematology processes, we identified a quality improvement opportunity concerning ordering, resource utilization, and timeliness for Unit Code 6100, MANUAL DIFFERENTIAL.

This Client Communication provides guidance as to the proper submission of Cytology and Histology (tissue) specimens in the best interest of patient care. Pathology Laboratories, Inc. (PathLabs) values your referrals and desires to work closely with providers and their medical staff to assure that quality reporting is achieved by following these recommended guidelines for specimen submission.

Pathology Laboratories, Inc. (PathLabs) is in the process of making updates to approximately eight (8) tests, which will be completed by Monday, August 21, 2023. These tests are performed by our reference laboratory partners; namely, Associated Regional University Pathologists (ARUP) of Salt Lake City, UT, National Medical Services (NMS) Labs of Horsham, PA, and Warde Medical Laboratory (Warde) of Ann Arbor, MI. Test updates relate to database changes made by these partners for the specified analytes.

Pathology Laboratories, Inc. (PathLabs) is in the process of making updates to approximately twenty (20) tests, which will be completed by Monday, July 17, 2023. These tests are performed by our reference laboratory partners; namely, Sonic Reference Laboratory (SRL) of Austin, TX, and American Esoteric Laboratories (AEL) of Memphis, TN. Both SRL and AEL are affiliates of Sonic Healthcare USA, Inc., as is PathLabs.

Full disclosure of the test updates is shown in the chart provided herein.

Pathology Laboratories, Inc. (PathLabs) is pleased to announce that we are bringing the STD (Sexually Transmitted Disease) testing for Chlamydia trachomatis (CT), Neisseria gonorrhea (NG), and Trichomonas vaginalis (TV) of urine specimens in-house effective December 27, 2022.

As a result of internalizing this testing, there are updates to our Urine STD tests; specifically for methodology, decreased analytic time, new collection devices, longer stability, and certain EMR code changes. In addition, Urine STD testing is no longer gender specific. However, an order code has been established for a male test for Trichomonas, using a swab collection device.

All testing updates are disclosed in the context of this publication and the chart provided below.

Pathology Laboratories, Inc. (PathLabs) is pleased to announce we will bring HPV, Pap, and STD (Sexually Transmitted Disease) Swab testing for Chlamydia trachomatis (CT), Neisseria gonorrhea (NG), and Trichomonas vaginalis (TV) in-house, effective Thursday, March 2, 2023.

As a result of internalizing this testing, PathLabs is in the process of updating our HPV, Pap, and STD Swab tests; specifically, to accommodate an expanded test menu, introduce a new methodology for molecular testing, convey decreased analytic times, present a new collection device for the Roche platform, and initiate EMR code changes.

As of June 12th, we are converting to a new Cytology/Histology Requisition (version 05/2023), shown at the end of this publication, to be used for ordering Cytology, Histology and Molecular testing. PathLabs’ sales team and supply department will be distributing the new requisition beginning next week.

All testing updates are disclosed in the context of this publication and provided in further detail in the charts below. All changes are marked in bright blue.

Pathology Laboratories, Inc. (PathLabs), in conjunction with our reference laboratory partners, is in the process of making updates to its test menu for various changes as fully described within the contents of this technical bulletin. Although some updates were effective in late April 2023, the majority are set for implementation on Monday, May 15, 2023, as disclosed in the chart provided herein.